New pricing strategies, a focus on improving broadband services, and a fiber expansion program are major growth drivers. The cost optimization initiative is improving profitability.

The company's strategic investment in MPLX allows it to allocate a significant portion of its free cash flow to investor returns.

Teladoc is a top player in the telehealth market and is consistently growing revenues and memberships; recent acquisitions will speed up growth.

Rising demand for ADAS, upbeat 2025 sales outlook and strong balance sheet are set to fuel Mobileye’s prospects.

Revenue diversification efforts and planned investment in new projects in Macao and Singapore bode well for the company.

T. Rowe Price’s strong liquidity position, product innovation and diverse AUM base support long-term growth. Strategic alliances and acquisitions will keep supporting its top-line growth.

Motorola is well-poised to benefit from organic growth and acquisition initiatives by entering into strategic alliances with other players in the ecosystem.

ATTR Amyloidosis Program is progressing well, while other programs are picking up pace. The collaboration with Regeneron is a boost to the company.

Solid investments in infrastructural development programs along with favorable rate outcome will help Edison International to boost its top line.

Solventum is leveraging a $93B TAM with strong global presence, trusted brands, and innovation across wound care, dental, and health IT. Margin expansion and restructuring savings, it for sustained growth and shareholder value.